OABI
OABI
NASDAQ · Life Sciences Tools & Services

Omniab Inc

$1.58
+0.01 (+0.64%)
As of Apr 1, 2:21 PM ET ·
Financial Highlights (FY 2026)
Revenue
38.87M
Net Income
-91,373,845
Gross Margin
Profit Margin
-235.1%
Rev Growth
-8.8%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 31.4% 31.4%
Operating Margin -282.3% -254.1% 6.8% 7.4%
Profit Margin -235.1% -223.3% 5.9% 5.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 38.87M 42.60M 184.39M 150.46M
Gross Profit 57.85M 47.20M
Operating Income -109,734,467 -108,243,117 12.45M 11.10M
Net Income -91,373,845 -90,132,025 10.85M 8.86M
Gross Margin 31.4% 31.4%
Operating Margin -282.3% -254.1% 6.8% 7.4%
Profit Margin -235.1% -223.3% 5.9% 5.9%
Rev Growth -8.8% -8.8% +2.4% +24.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 119.74M 97.60M
Total Equity 186.51M 185.21M
D/E Ratio 0.64 0.53
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -84,121,234 -87,587,869 16.49M 14.30M
Free Cash Flow 4.93M 6.48M